# Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer

> **NCT06656949** · NA · RECRUITING · sponsor: **Qilu Hospital of Shandong University** · enrollment: 42 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **PROCEDURE:** injecting indocyanine green (ICG) dye Intraoperative

## Key facts

- **NCT ID:** NCT06656949
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-30
- **Primary completion:** 2025-10-30
- **Final completion:** 2026-01-30
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2024-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06656949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06656949, "Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06656949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*